Researchers at San Raffaele Scientific Institute of Milanand University College London recently used a technique to implant genetically modified muscle cells into mice with muscular dystrophy. These mice were then able to perform more movement related actions, such as running longer on a treadmill, than mice who did not receive the treatment. “This technique may be useful in the future for treating limb-girdle muscular dystrophy and perhaps other forms of muscular dystrophy,” says leader of the study, Dr. Francesco Saverio Tedesco.
This study is another example of the growing field of translational genomics and the paradigm shift it is fostering in treating genetic disorders. As this study illustrates, researchers are taking advantage of the unique properties of stem cells to regenerate. Stem cells are collected and the gene abnormalities corrected; the stem cells are then expanded and differentiated into the appropriate tissue with the reprogrammed stem cells transplanted to replace the defective tissue; in this case, dystrophin producing muscle cells were introduced.
The promise of translational genomics is to treat previously untreatable diseases by addressing the root cause of the disease, in lieu of current treatments that focus on mitigating the symptoms of the disease. This research allows for the acceleration of stem cell applications, creating the possibility for viable treatment options for genetic diseases such as muscular dystrophy, as well as a myriad of other forms of disease, trauma, and injuries which were previously viewed us incurable.
As these treatments emerge, it is obvious that the best stem cells to use will be the patient’s own stem cells as their use eliminates the possibility of rejection and the need to take immune-suppression drugs. To learn more about how you can bank your own valuable stem cells, visit www.StemSave.com or call 877-783-6728 (877-StemSave) today.
The future of Regenerative Medicine is now.
To view the full article, click here.